BC PharmaCare: Your Voice



Get Involved

or

Read the Ongoing Results of this Engagement

 

What is this engagement about?

The Ministry of Health has two main goals for the BC PharmaCare program:

  • To cover drugs that support the health and well-being of British Columbians; and
  • To make sure that the drugs PharmaCare covers are affordable and give the best value for money.

To meet the first goal, PharmaCare covers a drug only if it has a proven record of safety and effectiveness. To meet the second goal, PharmaCare compares each drug to the drugs it already covers that treat the same condition. For example, if more than one drug provides the same health benefit, PharmaCare may cover only the drug(s) that offers the best value.

Before PharmaCare decides if it will cover a drug, the drug goes through a full review to find out if covering it aligns
with the goals above. Patients, caregivers and patient groups have the opportunity to add their voices to the drug
review process.
 
Drug(s) available for input:

    • Generic name: ranolazine
      Brand name: Corzyna
      Drug used for: stable angina pectoris in adults
    • Generic name: ofatumumab
      Brand name: Kesimpta
      Drug used for:  relapsing multiple sclerosis (RRMS)
    • Generic name: nintedanib
      Brand name: Ofev
      Drug used for:  chronic fibrosing interstitial lung diseases
    • Generic name: ozanimod
      Brand name:  Zeposia
      Drug used for:  relapsing multiple sclerosis (RRMS)

Input accepted: From Wednesday, December 23, 2020 to Wednesday, January 20, 2021 AT MIDNIGHT

    • Generic name: fremanezubab
      Brand name: Ajovy®
      Drug used for:  the prevention of migraine in adults who have at least 4 migraine days per month.

Input accepted: From Wednesday, January 20, 2021 to Wednesday, February 17, 2021 AT MIDNIGHT

To provide input, please visit http://www.gov.bc.ca/BCyourvoice.
 

How can my contribution make a difference?

All responses that are submitted during the open consultation are sent to the Drug Benefit Council. The Council takes the public’s input into consideration when they make their drug coverage recommendations. Drugs are posted for review on an ongoing basis.
 

Details of the Engagement:

Date: June 6, 2017

Status: Ongoing

Location: Province-wide

Category: Health & Safety

Types: Online

 

Get Involved

or

Read the Ongoing Results of this Engagement

 

Related consultations